Your browser doesn't support javascript.
loading
The Value of Tucatinib in Metastatic HER2-Positive Breast Cancer Patients: An Italian Cost-Effectiveness Analysis.
Antonazzo, Ippazio Cosimo; Cortesi, Paolo Angelo; Miceli Sopo, Gerardo; Mazzaglia, Giampiero; Conte, Pierfranco; Mantovani, Lorenzo Giovanni.
Affiliation
  • Antonazzo IC; Research Centre on Public Health, University of Milan-Bicocca, 20900 Monza, Italy.
  • Cortesi PA; Research Centre on Public Health, University of Milan-Bicocca, 20900 Monza, Italy.
  • Miceli Sopo G; UOC Farmacia Ospedaliera OP-Continuità Ospedale Territorio e Distribuzione Diretta, ASL Roma 2, Roma Ospedaliera OP-Continuità Ospedale Territorio e Distribuzione, 00157 Ariccia, Italy.
  • Mazzaglia G; Research Centre on Public Health, University of Milan-Bicocca, 20900 Monza, Italy.
  • Conte P; San Camillo Hospital, IRCCS, Venezia Lido, 30126 Venice, Italy.
  • Mantovani LG; Research Centre on Public Health, University of Milan-Bicocca, 20900 Monza, Italy.
Cancers (Basel) ; 15(4)2023 Feb 12.
Article in En | MEDLINE | ID: mdl-36831518

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Language: En Journal: Cancers (Basel) Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Language: En Journal: Cancers (Basel) Year: 2023 Document type: Article Affiliation country: Country of publication: